{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:47:27Z","timestamp":1790275647712,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 infection is generally regarded as an acute self-limiting illness in children, but it can cause significant morbidity and mortality in both healthy and high-risk children. There are limited data on the outcomes of children with congenital heart disease (CHD) and COVID-19. This study aimed to examine the risks of mortality, in-hospital cardiovascular and non-cardiovascular complications in this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from hospitalized pediatric patients from 2020 using the nationally representative National Inpatient Sample (NIS). Children hospitalized for COVID-19 were included, and weighted data were used to compare in-hospital mortality and morbidities between children with and without CHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 36,690 children admitted with a diagnosis of COVID-19 infection(ICD-10 code:U07.1 and B97.29) during calendar year 2020, 1240 (3.4%) had CHD. The risk of mortality in children with CHD was not significantly higher than those without CHD(1.2% vs. 0.8%, p\u2009=\u20090.50), with adjusted OR (aOR) of 1.7 (95% CI: 0.6\u20135.3). Tachyarrhythmias and heart block were more likely in CHD children with an aOR of 4.2 (95% CI: 1.8\u20139.9) and aOR of 5.0 (95% CI: 2.4\u201310.8), respectively. Similarly, respiratory failure [aOR\u2009=\u20092.0 (1.5\u20132.8)], respiratory failure requiring non-invasive mechanical ventilation [aOR\u2009=\u20092.7 (1.4\u20135.2)] and invasive mechanical ventilation [aOR\u2009=\u20092.6 (1.6-4.0)], and acute kidney injury [aOR\u2009=\u20093.4 (2.2\u20135.4)] were all significantly higher among patients with CHD. Median length of hospital stay in children with CHD was longer than those without CHD [5 days (IQR: 2\u201311) vs. 3 days (IQR: 2\u20135), p\u2009=\u2009&lt;\u20090.001].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children with CHD hospitalized with COVID-19 infection were at increased risk of serious cardiovascular and non-cardiovascular adverse clinical outcomes. They also had increased length of hospital stay and utilization of healthcare resources.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-023-04058-2","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:03:37Z","timestamp":1684206217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of congenital heart disease on outcomes among pediatric patients hospitalized for COVID-19 infection"],"prefix":"10.1186","volume":"23","author":[{"given":"Laxmi V","family":"Ghimire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman A.","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita J.","family":"Moon-Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"4058_CR1","unstructured":"Johns Hopkins University(JHU). Covid-19 dashboard by the Center for Systems Science and Engineering. Johns Hopkins Coronavirus resource center. https:\/\/coronavirus.jhu.edu\/map.html. Accessed 19 Nov 2022."},{"key":"4058_CR2","doi-asserted-by":"publisher","first-page":"e2211967","DOI":"10.1001\/jamanetworkopen.2022.11967","volume":"5","author":"L Ehwerhemuepha","year":"2022","unstructured":"Ehwerhemuepha L, Roth B, Patel AK, Heutlinger O, Heffernan C, Arrieta AC, et al. Association of congenital and Acquired Cardiovascular Conditions with COVID-19 Severity among Pediatric Patients in the US. JAMA Netw Open. 2022;5:e2211967.","journal-title":"JAMA Netw Open"},{"key":"4058_CR3","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.jacc.2020.08.056","volume":"76","author":"D Matsubara","year":"2020","unstructured":"Matsubara D, Kauffman HL, Wang Y, Calderon-Anyosa R, Nadaraj S, Elias MD, et al. Echocardiographic findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 in the United States. J Am Coll Cardiol. 2020;76:1947\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"4058_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.2800","author":"S Rao","year":"2022","unstructured":"Rao S, Lee GM, Razzaghi H, Lorman V, Mejias A, Pajor NM, et al. Clinical features and Burden of Postacute Sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.2800.","journal-title":"JAMA Pediatr"},{"key":"4058_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","volume":"142","author":"Z Belhadjer","year":"2020","unstructured":"Belhadjer Z, M\u00e9ot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute Heart failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 pandemic. Circulation. 2020;142:429\u201336.","journal-title":"Circulation"},{"key":"4058_CR6","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/S2352-4642(20)30272-8","volume":"4","author":"K Webb","year":"2020","unstructured":"Webb K, Abraham DR, Faleye A, McCulloch M, Rabie H, Scott C, et al. Multisystem inflammatory syndrome in children in South Africa. Lancet Child Adolesc Health. 2020;4:e38.","journal-title":"Lancet Child Adolesc Health"},{"key":"4058_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","volume":"69","author":"S Godfred-Cato","year":"2020","unstructured":"Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J, et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1074\u201380.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4058_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2102968","volume":"385","author":"AJ McArdle","year":"2021","unstructured":"McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, et al. Treatment of Multisystem Inflammatory Syndrome in Children. N Engl J Med. 2021;385:11\u201322.","journal-title":"N Engl J Med"},{"key":"4058_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347\u201358.","journal-title":"N Engl J Med"},{"key":"4058_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2102605","volume":"385","author":"MBF Son","year":"2021","unstructured":"Son MBF, Murray N, Friedman K, Young CC, Newhams MM, Feldstein LR, et al. Multisystem inflammatory syndrome in children - initial therapy and outcomes. N Engl J Med. 2021;385:23\u201334.","journal-title":"N Engl J Med"},{"key":"4058_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jama.2020.10370","volume":"324","author":"BW McCrindle","year":"2020","unstructured":"McCrindle BW, Manlhiot C. SARS-CoV-2-related inflammatory multisystem syndrome in children: different or shared etiology and pathophysiology as Kawasaki disease? JAMA: the journal of the American Medical Association. 2020;324:246\u20138.","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"4058_CR12","first-page":"51","volume":"38","author":"T Radia","year":"2021","unstructured":"Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51\u20137.","journal-title":"Paediatr Respir Rev"},{"key":"4058_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s13312-020-2025-1","volume":"57","author":"K Dhanalakshmi","year":"2020","unstructured":"Dhanalakshmi K, Venkataraman A, Balasubramanian S, Madhusudan M, Amperayani S, Putilibai S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome \u2014 temporally associated with SARS-CoV-2 (PIMS-TS) in indian children. Indian Pediatr. 2020;57:1010\u20134.","journal-title":"Indian Pediatr"},{"key":"4058_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a Pediatric Inflammatory Multisystem Syndrome temporally Associated with SARS-CoV-2. JAMA. 2020;324:259\u201369.","journal-title":"JAMA"},{"key":"4058_CR15","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet. 2020;395:1607\u20138.","journal-title":"The Lancet"},{"key":"4058_CR16","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa2203315","volume":"386","author":"CB Creech","year":"2022","unstructured":"Creech CB, Anderson E, Berthaud V, Yildirim I, Atz AM, Melendez Baez I, et al. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 years of age. N Engl J Med. 2022;386:2011\u201323.","journal-title":"N Engl J Med"},{"key":"4058_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa2209367","volume":"387","author":"EJ Anderson","year":"2022","unstructured":"Anderson EJ, Creech CB, Berthaud V, Piramzadian A, Johnson KA, Zervos M, et al. Evaluation of mRNA-1273 Vaccine in Children 6 months to 5 years of age. N Engl J Med. 2022;387:1673\u201387.","journal-title":"N Engl J Med"},{"key":"4058_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2116298","volume":"386","author":"EB Walter","year":"2022","unstructured":"Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, et al. Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. N Engl J Med. 2022;386:35\u201346.","journal-title":"N Engl J Med"},{"key":"4058_CR19","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1056\/NEJMoa2210058","volume":"387","author":"H Chemaitelly","year":"2022","unstructured":"Chemaitelly H, AlMukdad S, Ayoub HH, Altarawneh HN, Coyle P, Tang P, et al. Covid-19 Vaccine Protection among children and adolescents in Qatar. N Engl J Med. 2022;387:1865\u201376.","journal-title":"N Engl J Med"},{"key":"4058_CR20","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","volume":"39","author":"JIE Hoffman","year":"2002","unstructured":"Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890\u2013900.","journal-title":"J Am Coll Cardiol"},{"key":"4058_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12887-020-02344-x","volume":"20","author":"LV Ghimire","year":"2020","unstructured":"Ghimire LV, Chou F-S, Moon-Grady AJ. Impact of congenital heart disease on outcomes among pediatric patients hospitalized for influenza infection. BMC Pediatr. 2020;20:450.","journal-title":"BMC Pediatr"},{"key":"4058_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40121-016-0142-x","volume":"6","author":"PA Checchia","year":"2017","unstructured":"Checchia PA, Paes B, Bont L, Manzoni P, Sim\u00f5es EAF, Fauroux B, et al. Defining the risk and Associated Morbidity and Mortality of severe respiratory syncytial virus infection among infants with congenital heart disease. Infect Dis Ther. 2017;6:37\u201356.","journal-title":"Infect Dis Ther"},{"key":"4058_CR23","first-page":"6690695","volume":"2021","author":"H Esmaeeli","year":"2021","unstructured":"Esmaeeli H, Ghaderian M, Zanjani KS, Ghalibafan SF, Mahdizadeh M, Aelami MH. COVID-19 in children with congenital Heart Diseases: a Multicenter Case Series from Iran. Case Rep Pediatr. 2021;2021:6690695.","journal-title":"Case Rep Pediatr"},{"key":"4058_CR24","doi-asserted-by":"publisher","first-page":"1022183","DOI":"10.3389\/fcvm.2022.1022183","volume":"9","author":"SN Siagian","year":"2022","unstructured":"Siagian SN, Oetama S, Pohan FZ, Mendel B, Lelya O, Sakti DDA, et al. Clinical outcomes of COVID-19 infection in congenital heart disease: a single-center experience in Indonesia. Front Cardiovasc Med. 2022;9:1022183.","journal-title":"Front Cardiovasc Med"},{"key":"4058_CR25","unstructured":"Agency for Healthcare Research and Quality (AHRQ). National (Nationwide) Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp. Accessed 19 Nov 2022."},{"key":"4058_CR26","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jacc.2018.07.055","volume":"72","author":"JB Edelson","year":"2018","unstructured":"Edelson JB, Rossano JW, Griffis H, Dai D, Faerber J, Ravishankar C, et al. Emergency Department visits by children with congenital heart disease. J Am Coll Cardiol. 2018;72:1817\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"4058_CR27","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018."},{"key":"4058_CR28","volume-title":"RStudio: Integrated Development for R","author":"T RStudio","year":"2016","unstructured":"RStudio T. RStudio: Integrated Development for R. Boston, MA: RStudio, Inc.; 2016."},{"key":"4058_CR29","unstructured":"Lumley T. Survey: analysis of complex survey samples. R package version 3.35-1. 2019."},{"key":"4058_CR30","unstructured":"Yoshida K. tableone: Create \u201cTable\u00a01\u201d to Describe Baseline Characteristics. 2020."},{"key":"4058_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00246-021-02751-6","volume":"43","author":"DD Strah","year":"2022","unstructured":"Strah DD, Kowalek KA, Weinberger K, Mendelson J, Hoyer AW, Klewer SE, et al. Worse hospital outcomes for children and adults with COVID-19 and congenital heart disease. Pediatr Cardiol. 2022;43:541\u20136.","journal-title":"Pediatr Cardiol"},{"key":"4058_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/apc.apc_134_21","volume":"14","author":"S Sachdeva","year":"2021","unstructured":"Sachdeva S, Ramakrishnan S, Choubey M, Koneti NR, Mani K, Bakhru S, et al. Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: a multicentric study from India. Ann Pediatr Cardiol. 2021;14:269\u201377.","journal-title":"Ann Pediatr Cardiol"},{"key":"4058_CR33","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1161\/CIRCULATIONAHA.121.057833","volume":"145","author":"KF Downing","year":"2022","unstructured":"Downing KF, Simeone RM, Oster ME, Farr SL. Critical illness among patients hospitalized with Acute COVID-19 with and without congenital heart defects. Circulation. 2022;145:1182\u20134.","journal-title":"Circulation"},{"key":"4058_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa017","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Ogokeh C, Rha B, Weinberg GA, Staat MA, Selvarangan R, et al. Vaccine effectiveness against influenza hospitalization among children in the United States, 2015\u20132016. J Pediatr Infect Dis Soc. 2020. https:\/\/doi.org\/10.1093\/jpids\/piaa017.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"4058_CR35","doi-asserted-by":"crossref","unstructured":"Dionne A, Mah DY, Son MBF, Lee PY, Henderson L, Baker AL et al. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. Pediatrics. 2020;146.","DOI":"10.1542\/peds.2020-009704"},{"key":"4058_CR36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/aas.13806","volume":"65","author":"M Wetterslev","year":"2021","unstructured":"Wetterslev M, Jacobsen PK, Hassager C, J\u00f8ns C, Risum N, Pehrson S, et al. Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: a retrospective population-based cohort study. Acta Anaesthesiol Scand. 2021;65:770\u20137.","journal-title":"Acta Anaesthesiol Scand"},{"key":"4058_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/pace.14226","volume":"44","author":"L Dagher","year":"2021","unstructured":"Dagher L, Shi H, Zhao Y, Wetherbie A, Johnsen E, Sangani D, et al. New-onset atrial arrhythmias associated with mortality in black and white patients hospitalized with COVID-19. Pacing Clin Electrophysiol. 2021;44:856\u201364.","journal-title":"Pacing Clin Electrophysiol"},{"key":"4058_CR38","doi-asserted-by":"publisher","first-page":"e008920","DOI":"10.1161\/CIRCEP.120.008920","volume":"13","author":"MK Turagam","year":"2020","unstructured":"Turagam MK, Musikantow D, Goldman ME, Bassily-Marcus A, Chu E, Shivamurthy P, et al. Malignant arrhythmias in patients with COVID-19: incidence, Mechanisms, and outcomes. Circ Arrhythm Electrophysiol. 2020;13:e008920.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"4058_CR39","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.hrthm.2020.06.016","volume":"17","author":"A Bhatla","year":"2020","unstructured":"Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17:1439\u201344.","journal-title":"Heart Rhythm"},{"key":"4058_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s42003-022-03986-6","volume":"5","author":"J-Y Zhu","year":"2022","unstructured":"Zhu J-Y, Wang G, Huang X, Lee H, Lee J-G, Yang P, et al. SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA\/MAX complex-mediated increased glycolysis. Commun Biol. 2022;5:1039.","journal-title":"Commun Biol"},{"key":"4058_CR41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313.","journal-title":"Lancet"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-023-04058-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:06:54Z","timestamp":1684206414000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-023-04058-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4058"],"URL":"https:\/\/doi.org\/10.1186\/s12887-023-04058-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2391836\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. All protocols were determined by the University of California, San Francisco Institutional Review Board to be exempt with investigator certification. The Healthcare Cost and Utilization Project or HCUP, is a family of healthcare databases and related software tools and products developed through a Federal-State-Industry partnership and sponsored by the Agency for Healthcare Research and Quality or AHRQ. Investigators are given de-identified information without links to identifiers. Under the guidelines of the University of California, San Francisco Institutional Review Board informed consent is waived. Additionally, all authors have completed data use training from HCUP\/AHRQ as per their requirement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"240"}}